Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.39%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - Net assets
Net assets on the balance sheet as of March 2024 : $0.70 B
According to Sage Therapeutics
's latest financial reports the company has $0.70 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Sage Therapeutics - Net assets on balance sheet (from 2013 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.79 B | -36.17% |
| 2022-12-31 | $1.25 B | -27.55% |
| 2021-12-31 | $1.72 B | -16.57% |
| 2020-12-31 | $2.07 B | 119.37% |
| 2019-12-31 | $0.94 B | 9.47% |
| 2018-12-31 | $0.86 B | 81.5% |
| 2017-12-31 | $0.47 B | 29.02% |
| 2016-12-31 | $0.36 B | 112.16% |
| 2015-12-31 | $0.17 B | 42.51% |
| 2014-12-31 | $0.12 B | -486.49% |
| 2013-12-31 | $-31.54 M | 135.45% |
| 2012-12-31 | $-13.4 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | $21.18 M | -97.00% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $71.84 M | -89.82% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $5.31 B | 652.47% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $0.25 B | -64.29% | 🇺🇸 USA |